
Seraph 100
Seraph®️ 100 Microbind®️ Affinity Blood Filter
for Price / Quote
for Questions
ExThera’s proprietary Seraph 100 Microbind Affinity Blood Filter (Seraph 100) is a first-of-its kind, CE Marked, technology designed to reduce bloodborne pathogens during bloodstream infections. Validated in preclinical studies and in a clinical trial in Europe, the device promises to address significant unmet needs for immediate treatment, even before the pathogen is identified.
Seraph’s broad-spectrum ability to reduce the pathogen bioburden without harming the treated blood gives it many potential clinical applications. The company has evaluated the therapeutic use of Seraph 100 in a dialysis-like extracorporeal circuit for treating patients with both drug-resistant and drug-susceptible bloodstream infections.
Watch viedo here
Loading...
Surge Mechanical Ventilation During COVID-19
During the COVID-19 pandemic, many hospitals in the U.S. exceeded their... Read more
The Influence of COVID-19 on Intensivist Wellbeing
The COVID-19 pandemic has been challenging for healthcare systems around... Read more
Capnodynamic Monitoring to Assess PEEP in COVID-19
Optimal positive end-expiratory pressure (PEEP) level during mechanical... Read more
JOIN OUR MANAGEMENT COMMUNITY